ALMS – alumis inc. (US:NASDAQ)
Stock Stats
News
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, BECN, SLRN, ALMS on Behalf of Shareholders
Alumis Inc. (NASDAQ: ALMS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan
Alumis Inc. (NASDAQ: ALMS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Form EFFECT ALUMIS INC.
Form 424B3 ALUMIS INC.
Form 4 ALUMIS INC. For: Apr 01 Filed by: Colowick Alan
Form 4 ALUMIS INC. For: Apr 01 Filed by: Babler Martin
Form S-4/A ALUMIS INC.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.